Icon

ZOFRAN ODT (nda020781)- (4MG,8MG)

ONDANSETRON SANDOZ
4MG,8MG
Yes No
2016-May-14 Expired
None None
None No
ZOFRAN is a 5-HT3 receptor antagonist indicated for the prevention of: • nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m2. • nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. • nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. • postoperative nausea and/or vomiting.
8 0 6
Total Other Developers None
Drugs with Suitability Yes
4MG ** ** - - 4
8MG ** ** - - 4
NDA Sales Available Total Generic Sales Available
No 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ********* ********* *************** *******, ***. *********** ** ******* *****, *** ***** ******, *******, *** **** (**) *****, ****** ****** (***) ***
****** *** ***** **** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ****** ****** ******* ******* *********** **** **. *-*/* *** *-*, *** ********** **** ***** *****, ******* *****, **** ******, *********** ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** *-*, ******* ********** ******, *******-******,, ***, ** ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.